1. Home
  2. ACET vs GAIA Comparison

ACET vs GAIA Comparison

Compare ACET & GAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

N/A

Current Price

$2.48

Market Cap

28.0M

Sector

Health Care

ML Signal

N/A

Logo Gaia Inc.

GAIA

Gaia Inc.

N/A

Current Price

$1.29

Market Cap

32.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
ACET
GAIA
Founded
1947
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
28.0M
32.9M
IPO Year
2017
1999

Fundamental Metrics

Financial Performance
Metric
ACET
GAIA
Price
$2.48
$1.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
★ $29.00
$3.38
AVG Volume (30 Days)
★ 284.0K
75.7K
Earning Date
11-05-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.18
EPS
N/A
★ N/A
Revenue
N/A
★ $4,500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 12.50
52 Week Low
$0.46
$1.16
52 Week High
$9.97
$4.26

Technical Indicators

Market Signals
Indicator
ACET
GAIA
Relative Strength Index (RSI) 15.77 47.65
Support Level N/A $1.19
Resistance Level $9.51 $1.47
Average True Range (ATR) 0.26 0.05
MACD 0.08 -0.00
Stochastic Oscillator 6.57 29.66

Price Performance

Historical Comparison
ACET
GAIA

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

Share on Social Networks: